Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
11/13/1998 | CA2230971A1 G-protein coupled receptor (hofnh30) |
11/12/1998 | WO1998050413A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
11/12/1998 | WO1998050412A1 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring |
11/12/1998 | WO1998050367A1 Processes and intermediates for preparing substituted indazole derivatives |
11/12/1998 | WO1998050032A1 BETA-LACTAM INHIBITORS OF CoA-IT |
11/12/1998 | CA2289008A1 Estrenes |
11/12/1998 | CA2288999A1 B-ring estratrienes |
11/12/1998 | CA2288986A1 Beta-lactam inhibitors of coa-it |
11/11/1998 | EP0877083A1 A novel human G-protein coupled receptor (HCEPT09) |
11/11/1998 | EP0877030A2 EPO primary response gene 1,(EPRG1) |
11/11/1998 | EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
11/11/1998 | EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
11/11/1998 | EP0876347A1 Quinoline derivatives |
11/11/1998 | EP0766570A4 Methods for treating respiratory disease |
11/11/1998 | EP0693921A4 Anti-oxidant alkylaryl polyether alcohol polymers |
11/11/1998 | CN1198775A Recombinant c-proteinase and processes, methods and uses thereof |
11/11/1998 | CN1040646C Enatiomeric hydroxylated xanthine compound |
11/10/1998 | US5834483 Method of treating heart failure with endothelin antagonists |
11/10/1998 | US5834470 Decongestants; bronchodilator and antisecretory and -tussive agents; side effect reduction |
11/10/1998 | US5834469 Endothelin receptor antagonists |
11/10/1998 | US5834238 Human GTP binding protein |
11/10/1998 | US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides |
11/10/1998 | CA2073005C Antimuscarinic bronchodilators |
11/07/1998 | CA2231754A1 A novel human g-protein coupled receptor hcept09 |
11/07/1998 | CA2230986A1 Epo primary response gene 1, eprg1 |
11/05/1998 | WO1998049319A1 Human lysophospholipase |
11/05/1998 | WO1998049191A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
11/05/1998 | WO1998049169A1 Phosphodiesterase 4-inhibiting diazepinoindolones |
11/05/1998 | WO1998049167A1 Condensed pyridazine derivatives, their production and use |
11/05/1998 | WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
11/05/1998 | WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders |
11/05/1998 | WO1998049131A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
11/05/1998 | WO1998048875A1 Method of delivering halotherapy |
11/05/1998 | WO1998048805A1 Pharmaceutical composition for supressing type 2 helper t cell immune response |
11/05/1998 | DE19718334A1 Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New benzylamine derivatives and phenylethylamine derivatives, processes for their preparation and their use as medicaments |
11/05/1998 | CA2288257A1 Method of delivering halotherapy |
11/05/1998 | CA2288073A1 Human lysophospholipase |
11/05/1998 | CA2285264A1 Condensed pyridazine derivatives, their production and use |
11/05/1998 | CA2278217A1 Phosphodiesterase 4-inhibiting diazepinoindolones |
11/04/1998 | EP0875566A2 Novel G-protein coupled receptor (HFGAN72X) |
11/04/1998 | EP0875565A2 Novel G-protein coupled receptor (hfgan72y) |
11/04/1998 | EP0874843A1 Novel substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases |
11/04/1998 | EP0874824A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
11/04/1998 | EP0874823A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
11/04/1998 | EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors |
11/04/1998 | EP0874800A1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity |
11/04/1998 | EP0874621A1 Pharmaceutical compositions |
11/04/1998 | EP0714392B1 Heterocycles useful as neurokinin antagonists |
11/04/1998 | CN1198096A C-proteinase inhibitor for treatment of disorders related to overproduction of collagen |
11/03/1998 | US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them |
11/03/1998 | US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition |
11/03/1998 | US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily |
11/03/1998 | US5830454 Mouse models of human disease |
11/03/1998 | US5830436 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
11/03/1998 | US5829449 Smoking products containing antioxidants |
10/30/1998 | CA2231748A1 Novel g-protein coupled receptor (hfgan72x) |
10/30/1998 | CA2231741A1 Novel g-protein coupled receptor (hfgan72y) |
10/29/1998 | WO1998048016A1 Edg-1-like receptor |
10/29/1998 | WO1998047534A1 Stabilized medicaments containing cysteinyl derivatives |
10/29/1998 | WO1998047511A1 Use of mizolastine for preparing a medicine for treating inflammation |
10/29/1998 | WO1998047501A1 Pharmaceutical preparation containing nimesulide for oral administration |
10/29/1998 | WO1998047483A1 Confectionery compositions |
10/29/1998 | WO1998047482A1 Throat soothing compositions |
10/29/1998 | CA2286865A1 Edg-1-like receptor |
10/28/1998 | EP0873338A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
10/28/1998 | EP0873337A1 Salts of n-(4-oxo-2-(1h-tetrazoyl-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide |
10/28/1998 | EP0873336A1 Antagonists of gonadotropin releasing hormone |
10/28/1998 | EP0873331A1 Benzofuran carboxamides and sulphonamides |
10/28/1998 | EP0873330A1 Diarylalkenylamine derivatives |
10/28/1998 | EP0873311A1 Tri-aryl ethane derivatives as pde iv inhibitors |
10/28/1998 | EP0873310A1 Diphenyl pyridyl ethane derivatives as pde iv inhibitors |
10/28/1998 | EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
10/28/1998 | EP0873301A1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
10/28/1998 | EP0701565B1 New prednisolone derivates |
10/28/1998 | EP0649418B1 7-(2-aminoethyl)-benzothiazolones |
10/28/1998 | CN1040423C Enzymatic resolution of endo bicycle [2.2.1] heptan-2-ol and derived pharmaceutical agents |
10/27/1998 | US5827869 Substituted biphenyl isoxazole sulfonamides |
10/27/1998 | US5827868 Prostaglandin analogs |
10/27/1998 | US5827849 Cyclic dericatives, pharmaceutical compositions containing these compounds and processes for preparing them |
10/27/1998 | US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease |
10/27/1998 | US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid |
10/27/1998 | US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology |
10/27/1998 | CA2102179C Quinuclidine derivatives |
10/27/1998 | CA1340104C 23-deoxy derivatives of ll-f28249 compounds |
10/22/1998 | WO1998046781A2 Novel transgene expression system for increased persistence |
10/22/1998 | WO1998046779A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3 |
10/22/1998 | WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA |
10/22/1998 | WO1998046611A1 Compounds |
10/22/1998 | WO1998046606A1 Novel compounds |
10/22/1998 | WO1998034949A3 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
10/22/1998 | WO1998002190A3 Cationic amphiphile/dna complexes |
10/22/1998 | CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna |
10/22/1998 | CA2287076A1 Novel transgene expression system for increased persistence |
10/22/1998 | CA2286789A1 Compounds |
10/22/1998 | CA2286580A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3 |
10/22/1998 | CA2286078A1 Novel compounds |
10/22/1998 | CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
10/22/1998 | CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
10/21/1998 | EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor |
10/21/1998 | EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof |